__________________________________________________________________________________________
30/JUN/2014
Re: Local ID TH140503804/ TH201405009378 FU (1)
Thank you for reporting to us an adverse event related to Lilly product.
We would like to collect more information to better understanding the reported event.
Please respond to following questions regarding the adverse event – some swelling on ankles and feet, involving a female patient, 65 Yrs. who was subscribed Forteo, reported the event to Lilly on 26/MAY/2014.
Please attempt to provide the following information with Dr.Tassanee Kitti-amnuaychai (Rajavithi Hospital):
1. Medical history
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
2. Any lab test or diagnosis performed due to events?
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
3. Corrective treatment received
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
4. Current outcome from the events.
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
5. Do you consider the events as causally related to Forteo treatment?
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
Thanks
Yours sincerely,
ELI LILLY AND COMPANY
Sasithorn Suntharo
Pharmacovigilance Associate
HCP’s signature:
Date:
__________________________________________________________________________________
For Eli Lilly internal use only
Date of Confirmation of FU request sent to HCP:
Name and Designation: